Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹1,360.90
Market cap: ₹1,944 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 44.4×Sector 50.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Sep 2026 18:28 IST BSE

Capital Structure Change

Fredun Pharmaceuticals Capital Structure Change

Fredun Pharmaceuticals allotted 3,61,599 equity shares following the conversion of 1,20,533 warrants. This allotment was executed at an issue price of Rs. 1,250 per warrant.

Value: ₹15.07 Cr

Read the filing ↗

22 Sep 2026 09:20 IST BSE

Acquisition

Fredun Pharmaceuticals Acquisition Worth ₹300 Cr

Fredun Pharmaceuticals acquired a 26% stake in ₹300 Crore-valued Goodman Vetcare, a dedicated pet pharmacy chain. Plans target PAN-India expansion with ~₹100 Cr revenue by FY31.

Value: ₹300.0 Cr
new pet pharmacy stores planned: 8.0 stores

Read the filing ↗